Cargando…

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Fibroblast Growth Factor 23- Phosphate Axis

PURPOSE: Despite management advances, accelerated atherosclerotic cardiovascular disease (ACVD) remains a major cause of morbimortality in systemic lupus erythematosus (SLE) patients; that is not fully explained by traditional risk factors. Fibroblast growth factor-23 (FGF23) is a bone-derived phosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ammar, Yaser, Mohamed, Amira, Khalil, Gihane, Maharem, Dalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407679/ https://www.ncbi.nlm.nih.gov/pubmed/34475774 http://dx.doi.org/10.2147/IJNRD.S326399

Ejemplares similares

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014)

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
por: Fernández-Cladera, Yolanda, et al.
Publicado: (2023)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
por: Teixeira, Vítor, et al.
Publicado: (2018)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
por: Dziedzic-Oleksy, Hanna, et al.
Publicado: (2022)

Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus
por: BALCI, Mehmet Ali, et al.
Publicado: (2021)

The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease
por: Yamada, Hodaka, et al.
Publicado: (2016)

Deterioration of Phosphate Homeostasis Is a Trigger for Cardiac Afterload　― Clinical Importance of Fibroblast Growth Factor 23 for Accelerated Aging ―
por: Mizuno, Yuji, et al.
Publicado: (2022)

The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE (−/−) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
por: Richez, Christophe, et al.
Publicado: (2013)

Activation of transforming growth factor-β(1 )and early atherosclerosis in systemic lupus erythematosus
por: Jackson, Michelle, et al.
Publicado: (2006)

Establishing a Risk Prediction Model for Atherosclerosis in Systemic Lupus Erythematosus
por: Xing, Haiping, et al.
Publicado: (2021)

Periodontitis is associated with higher subclinical atherosclerosis in patients with systemic lupus erythematosus
por: Zamora‐Pasadas, Mónica, et al.
Publicado: (2022)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
por: Mike, Elise V., et al.
Publicado: (2018)

CORRIGENDUM: Deterioration of Phosphate Homeostasis Is a Trigger for Cardiac Afterload　― Clinical Importance of Fibroblast Growth Factor 23 for Accelerated Aging ―
por: Mizuno, Yuji, et al.
Publicado: (2023)

Acute Myocardial Infarction as the First Presentation of Systemic Lupus Erythematosus in a 23-Year-Old Patient
por: Ayyad, Mohammed, et al.
Publicado: (2023)

Evaluation of the P Wave Axis in Patients With Systemic Lupus Erythematosus
por: Acar, Rezzan Deniz, et al.
Publicado: (2015)

Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats
por: Arai-Nunota, Noriko, et al.
Publicado: (2014)

Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
por: Westerberg, Per-Anton, et al.
Publicado: (2012)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Analyzing the pathogenesis of systemic lupus erythematosus complicated by atherosclerosis using transcriptome data
por: Wang, Yimin, et al.
Publicado: (2022)

Incidence and Risk of Infection in Egyptian Patients with Systemic Lupus Erythematosus
por: Mohamed, Dalia F, et al.
Publicado: (2014)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008)

Fecal carriage of ESBL-producing Escherichia coli in Egyptian patients admitted to the Medical Research Institute hospital, Alexandria University
por: ElBaradei, Amira, et al.
Publicado: (2020)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)

IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus
por: Ding, Xuewei, et al.
Publicado: (2020)

Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus
por: Medeiros, Priscila B. S., et al.
Publicado: (2021)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients
por: Nomair, Azhar Mohamed, et al.
Publicado: (2016)

A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2014)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Genome-wide association study for systemic lupus erythematosus in an egyptian population
por: Elghzaly, Ashraf A., et al.
Publicado: (2022)

Relation between Vitamin D Level and Cyclin-Dependent Kinase-1 Gene Expression in Egyptian Patients with Lupus Nephritis and their Impact on Disease Activity
por: Osman, Eman M. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvdbr73ger6bgsd52natjvh0h4